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E-mail address: wiech@awf.gda.pl (W. Ziolkowski)There is growing evidence of mitochondrial membrane raft-like microdomains that are involved in
the apoptotic pathway. The aim of this study was to investigate the effect of methyl-beta-cyclodex-
trin (MbCD), being a well-known lipid microdomain disrupting agent and cholesterol chelator, on
the structure and bioenergetics of rat liver mitochondria (RLM). We observed that MbCD decreases
the function of RLM, induces changes in the mitochondrial conﬁguration state and decreases the
calcium chloride-induced swelling. These data suggest that disruption of mitochondrial raft-like
microdomains by cholesterol efﬂux on one hand impairs mitochondrial bioenergetics, but on the
other hand it protects the mitochondria from swelling.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
There are at least four main membrane lipid microdomains
located within the plasma membrane, mitochondrial membranes,
golgi apparatus and endoplasmic reticulum [1–4]. The plasma
membrane ‘‘lipid rafts” consist of cholesterol and sphingolipids [1].chemical Societies. Published by E
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.There is also growing evidence suggesting the existence of
mitochondrial raft-like microdomains [4,5], which are involved in
the signaling pathways controlling the apoptotic process [6,7].
Even if the cholesterol content in mitochondria is lower than in
other organelles, its appropriate level for mitochondrial raft-like
microdomains seems to be crucial [4,5]. In rat liver mitochondria
(RLM), cholesterol is mainly distributed within the areas of outer
membrane (OM), involved in creation of mitochondria contact sites
[8], joining mitochondrial membranes, where voltage-dependent
anion channel (VDAC) is localized on the inside or outside of cho-
lesterol-containing lipid raft-like areas [9].
Mitochondrial contact sites are also associated with the mito-
chondrial permeability transition pore (mPTP) being a multipro-
tein complex, comprising, among others, adenine nucleotide
translocator (ANT), VDAC, peripheral benzodiazepine receptor,
creatine kinase, hexokinase II, cyclophiline D, and BAX/Bcl-2-like
proteins. Activation of mPTP is associated with mitochondriallsevier B.V. All rights reserved.
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of mitochondria and release of death-promoting factors like
cytochrome c [10]. There are many factors implicated in mPTP reg-
ulation, i.e., oxidative stress [11], mitochondrial GSH depletion,
Ca2+ and Pi, lowering of extramitochondrial ATP [12], and ADP level
[13], collapse of mitochondrial membrane potential, and decrease
of matrix pH [14,15]. In addition, it has been shown that mitochon-
drial raft-like microdomain speciﬁc lipids play a key role in the reg-
ulation of mPTP [5]. Furthermore, it has been proposed that lipid
microdomains, enriched in cholesterol and ceramide, could coexist
as structural elements with somemPTP-forming proteins, and with
members of the Bcl-2 family [16]. In the reperfused rat heart mod-
el, the release of cytochrome c from mitochondria correlates with
Bax insertion into the mitochondrial detergent-resistant mem-
branes (mDRMs), which are abundant in VDAC, ANT, cholesterol
and ceramide [16].
Methyl-beta-cyclodextrin (MbCD) belongs to the b-cyclodex-
trin family, being capable of removing cholesterol from the plas-
ma membrane [17]. The methylated form is more efﬁcient
cholesterol chelator than non-methylated b-cyclodextrin [18].
MbCD molecule has an internal hydrophobic cavity that can
accommodate normally insoluble compounds such as cholesterol.
The surface hydrophilicity of cyclodextrin-cholesterol complex
accounts for its solubility in aqueous solutions [19]. Garofalo
et al. [4] reported that MbCD-induced disruption of raft-like
microdomains in isolated mitochondria from human lymphoblas-
toid CEM cells prevented mitochondria depolarization and cyto-
chrome c release after treatment with disialoganglioside (GD3)
or t-Bid, pro-apoptotic protein. Also in another study, an inhibi-
tory effect of MbCD on rBAX-induced opening of mPTP was ob-
served [5]. MbCD lowered cholesterol and ganglioside content
in the mitochondria of control rat kidney cortex. Similar resis-
tance to mPTP opening induced by rBAX, was observed in kidney
mitochondria from hypothyroid rats that were characterized by
lower cholesterol and ganglioside content [5]. Overall, these data
suggest that lipid composition of mitochondrial membrane raft-
like microdomains may play an important role in the regulation
of early stages of apoptosis.
Therefore, we hypothesized that the disruption of mitochon-
drial raft-like microdomains by cholesterol removal could affect
the mitochondrial structure and energetic metabolism.2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma (St. Louis, MO, USA),
except for BSA (Merck, Damstadt, Germany).
2.2. Animals
All experiments were approved by the Local Ethical Committee
at the Medical University in Gdansk (Consent No. 13/2007).
Wistar rats weighing 250–300 g were housed in an environ-
mentally controlled room (23 ± 1 C, 12 h/12 h light–dark cycle),
and received standard rat chow and water ad libitum.
2.3. Isolation of RLM
Mitochondria were isolated as described earlier [20]. The qual-
ity of mitochondrial preparation was checked by Western-blotting
analysis. Further puriﬁcation of crude mitochondria, and isolation
of mitochondria-associated membranes (MAM) fraction and pure
mitochondria were performed as previously described [21]. Mito-
chondrial and MAM lysates (40 lg of protein/lane) were separatedby SDS–PAGE on 10% gel and transferred onto PVDF membrane
(BioRad). Membranes were blocked using 2% non-fat milk in TBS
buffer with 0.01% Tween-20 for 1 h. The purity of mitochondrial
and MAM fractions was checked using speciﬁc antibodies against
ADP/ATP carrier (ANT), plasma membrane Ca2+-ATPase (PMCA)
and sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) followed
by incubation with secondary HRP-conjugated antibodies. During
the experiment, mitochondria were kept in the form of suspension
containing 30–50 mg of protein per 1 ml. The protein content was
estimated according to the method of Lowry et al. [22].
2.4. Cholesterol estimation
Isolated RLM (1 mg of protein/ml) were incubated with control
respiration buffer or with the buffer containing 2% or 4% MbCD.
After 5 min of incubation, samples were centrifuged at 10 000 g
for 10 min, and mitochondrial cholesterol was determined as pre-
viously described [23].
2.5. Mitochondrial respiratory activity assay
Mitochondrial oxygen uptake was measured at 25 and 37 C
with the Clark oxygen electrode using Gilson Polarograph. The res-
piration medium contained 170 mM sucrose, 15 mM KCl, 5 mM
potassium phosphate, 0.1 mM EDTA, 0.1% BSA, and 5 mM succinate
(pH 7.4) was used as an oxidizable substrate. Mitochondria (1 mg
of protein/ml) were incubated for 2.5 min in the medium without
(control) or in the presence of 2% or 4% of MbCD. Respiratory con-
trol index (RCI) and ADP/O were measured and calculated from
oxygen electrode traces as previously described [24].
2.6. Mitochondrial enzyme activities measurement
The activity of cytochrome c oxidase (COX) was measured
according to [25] and the activity of rotenone-insensitive NADH
cytochrome c reductase was assessed according to [26]. Enzymatic
activities measured in mitochondrial pellet (1 mg of protein/ml)
obtained after 5 min incubation with respiration buffer were ex-
pressed as 100%. The activity of the enzymes assessed in other
cases were compared to the control and expressed as percentage
of control activity.
2.7. Swelling of the RLM
The measurement of RLM swelling was performed spectropho-
tometrically as previously described [27]. CaCl2 (100 lM) was used
as mPTP opening inducer and cyclosporin A (CSA, 1 lM) as mPTP
opening inhibitor. 1 mg of RLM was added to the buffer supple-
mented with 1 mM succinate and 1 lM rotenone in the presence
or absence of 2% or 4% of MbCD.
2.8. EM analyses
Mitochondria (1 mg of protein) were incubated for 5 min with
control buffer or buffer supplemented with 2% or 4% of MbCD, or
0.25% digitonin, then ﬁxed and processed for electron microscopy
as previously described [28].
2.9. Data analysis
Statistical analysis was performed using a dedicated software
package (Statistica v. 7.0, Stat Soft Inc.). Results are expressed as
mean ± standard error of the mean (S.E.M.). Differences between
means were tested using one-way ANOVA test. The statistical sig-
niﬁcance was established at P < 0.05.
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3.1. The effect of MbCD on mitochondrial cholesterol content
First, we checked the inﬂuence of 2% or 4% MbCD on cholesterol
status in RLM (Fig. 1). The mean level of total pool of cholesterol in
control RLM was 37.5 ± 3.8 disintegrations per minute (DPM) per
mg of mitochondrial protein. Both 2% and 4% MbCD signiﬁcantly
decreased mitochondrial cholesterol to 18.4 ± 4.2 and 10.8 ± 2.9,
respectively.
3.2. MbCD decreased activity of rotenone-insensitive NADH
cytochrome c reductase
Next, we measured COX and rotenone-insensitive NADH cyto-
chrome c reductase activities in order to observe the effect of mito-Fig. 1. MbCD induced cholesterol depletion in RLM. RLM were treated with 0%, 2%
or 4% MbCD for 5 min and cholesterol content was evaluated in the mitochondrial
pellets. The amount of cholesterol in the mitochondrial pellet was measured using
radioactive assay, was expressed as disintegrations per minute (DPM) per 1 mg of
mitochondrial protein. All data are means ± S.E.M. of at least six independent
experiments. a,bP < 0.001 is signiﬁcantly different as compared with 0%.
Fig. 2. MbCD-induced mitochondrial cholesterol depletion leads to diminished
rotenone-insensitive NADH cytochrome c reductase activity. The enzyme activities
of marker mitochondrial membranes: OM – rotenone-insensitive NADH cyto-
chrome c reductase and IM – cytochrome c oxidase, were measured in mitochon-
drial pellets obtained after incubation with control respiratory buffer 0% (without
MbCD), 2% or 4% MbCD. Enzyme activities are expressed as percentage of the
relevant control activities. Cytochrome c oxidase (h) and rotenone-insensitive
NADH cytochrome c reductase (j) activities: a,b signiﬁcantly differed as compared
with control buffer (P < 0.01 and P < 0.001, respectively); c was signiﬁcantly
different as compared with 2% MbCD (P < 0.01). All data are presented as
means ± SEM of at least six independent experiments.chondrial cholesterol removal on enzymes localized within inner
and outer mitochondrial membranes, respectively. As shown in
Fig. 2, COX activity was insigniﬁcantly lower after MbCD treat-
ment, while the activity of rotenone-insensitive NADH cytochrome
c reductase decreased by 17% or 35% at 2% or 4% MbCD,
respectively.
3.3. The effect of MbCD on mitochondrial bioenergetics
One of the main characteristics of mitochondrial function is RCI
deﬁned as a ratio of oxygen consumption rate in the presence of
ADP to that one observed in the absence of ADP. At 25 C, 2% MbCD
insigniﬁcantly lowered RCI from 6.4 ± 0.8 to 5.5 ± 0.8, while 4%
MbCD caused RCI decrease to 1.3 ± 0.03 (with P < 0.001).
A more evident effect of MbCD on RCI was observed at 37 C.
After incubation of RLM with 2% of MbCD, RCI was signiﬁcantly de-
creased from 4.5 ± 0.9 to 2.5 ± 0.3 (with P < 0.01). In the presence of
4% of MbCD the rate of oxygen consumption was not stimulated by
ADP.
Similarly to RCI, at 25 C only 4% MbCD signiﬁcantly decreased
ADP/O ratio (a marker of mitochondrial coupling) from 2.0 ± 0.1 to
1.5 ± 0.1 (P < 0.001). However, at 37 C mitochondria respiration
was also insensitive to ADP addition after treatment of 4%MbCD,
whereas 2% MbCD decreased ADP/O ratio from 2.0 ± 0.1 to
1.7 ± 0.1 (P < 0.01).Fig. 3. MbCD-induced mitochondrial conﬁguration change. Electron micrographs of
mitochondria from rat liver were isolated and prepared as previously described
[28]. Mitochondria were untreated (0% MbCD – Fig. 3A) or were incubated with 2%
MbCD (Fig. 3B), 4% MbCD (Fig. 3C), or 0.25% of digitonin (Fig. 3D), as described in
Section 2. MbCD-induced conﬁguration state change of RLM from aggregated to
orthodox was observed (Fig. 3B and C). Mitochondria were completely disrupted
when treated with digitonin (Fig. 3D). Bar, 2 lm.
Fig. 4. Dual effect of MbCD on mitochondrial swelling. Mitochondrial swelling induced by MbCD or calcium chloride was assessed spectrophotometrically. Figure on the right
(2 min of preincubation with control buffer, 2% or 4% of MbCD) shows the effect of MbCD onmitochondrial swelling. When calcium chloride was not present in the incubation
medium, 4% MbCD, induced mitochondrial swelling which was not inhibited by 1 lM CSA. Figure on the left: after 2 min of preincubation (positive control) 100 lM of
calcium chloride was added. Inhibitory effect of CSA (added at the beginning of incubation) was observed. MbCD partially reduced CaCl2-induced swelling. Arrow indicates
the time when CaCl2 was added. The typical curves of at least three independent experiments are presented.
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orthodox conﬁguration
Electron microscopic analyses have shown that MbCD treat-
ment of isolated RLM induced conformational changes. As shown
in Fig. 3, the control mitochondria were mostly in the aggregated
state, while MbCD treatment increased the number of mitochon-
dria in orthodox conﬁguration in a concentration dependent man-
ner. Digitonin, an another compound that is able to disrupt
mitochondrial OM, completely disrupted RLM structure (Fig. 3D).
3.5. Mitochondrial swelling induced by calcium chloride is ameliorated
by cholesterol depletion
MbCD, during 2 min incubation period preceding CaCl2 addi-
tion, induced swelling of RLM at 4%, whereas 2% MbCD had almost
no effect (Fig. 4). We did not observe any swelling of control as well
as 2% MbCD treated mitochondria for the next 20 min (data not
shown).
However, the mitochondrial swelling induced by calcium chlo-
ride was partially prevented by cholesterol depletion (Fig. 4). The
inhibitory effect of MbCD on RLM swelling was more efﬁcient at
2% as compared to 4% concentration. CSA, an inhibitor of mPTP
opening, partially decreased RLM swelling induced by CaCl2 in
the presence of 4% MbCD, and completely blocked CaCl2 induced
swelling in the presence or absence of 2% MbCD.
4. Discussion
In the present study we demonstrated, that MbCD-induced
depletion of mitochondrial cholesterol, being the main component
of mitochondrial raft-like microdomains or mDRMs, impaired
mitochondrial bioenergetics. Despite of this fact, the MbCD treat-ment increased mitochondria resistance to calcium chloride-in-
duced swelling.
Appropriate cholesterol content in the mitochondria is impor-
tant for normal function of the organelle, and cholesterol over-
accumulation or decreased cholesterol levels have been observed
under physiological and pathological conditions [5,29–31]. For
example, reduced cholesterol level was detected in rat hypothyroid
kidney cortex mitochondria [5] as well as in rat heart mitochondria
isolated after long lasting endurance exercise [30].
A new role of cholesterol as a key element in mitochondrial raft-
like microdomain structure has been proposed by group of Zazueta
[5]. The changes in mitochondrial cholesterol pool induced by
MbCD treatment may inﬂuence mitochondrial contact site compo-
nents. Mitochondrial contact sites and further mPTP, are impli-
cated in mitochondrial apoptotic pathway [12]. Therefore, we
hypothesized that disruption of mitochondrial raft-like microdo-
mains by MbCD treatment can prevent the changes observed in
mitochondria during an early stage of apoptosis like impairment
of mitochondrial bioenergetics and swelling.
In addition, we observed that MbCD was able to induce the
change of RLM conﬁguration state from aggregated to orthodox.
According to Ardail et al. [8] the majority of mitochondrial choles-
terol is located non-homogenously within dynamic structures
called contact sites, which are implicated in the physiological con-
trol of mitochondrial ultrastructure, e.g., orthodox vs. aggregated
transition, as well as mitochondrial bioenergetics. Our results
showed that cholesterol depletion shifts mitochondrial conﬁgura-
tion state from the aggregated to orthodox one. In addition, deple-
tion of mitochondrial cholesterol, as observed in hypothyroid
mitochondria, may inﬂuence the rate of ATP synthesis and de-
crease the efﬁciency of oxidative phosphorylation [32].
MbCD is known to induce membrane cholesterol efﬂux and
ultimately disruption of mitochondrial raft-like microdomains
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et al. [33] observed that external NADH oxidation depends on a
number of contact sites. The enzyme responsible for this oxidation
is rotenone-insensitive NADH cytochrome c reductase. We have
shown that MbCD signiﬁcantly reduced the activity of the enzyme,
which indeed suggests that this reductase is functionally con-
nected with mitochondrial raft-like microdomains. Moreover, dif-
ferent effects of MbCD on COX and rotenone-insensitive NADH
cytochrome c reductase activities can be explained by heterogenity
of cholesterol distribution in RLM. As RLM cholesterol is localized
mainly within the OM, we suspected that MbCD inﬂuences more
mitochondrial outer rather than inner membrane enzyme activi-
ties. The results presented on Fig. 2 conﬁrm our hypothesis.
When the swelling of mitochondria was stimulated by calcium
chloride, MbCD partially inhibited this process. These data are in
agreement with previously reported studies, showing that the dis-
ruption of mitochondrial lipid microdomains by MbCD, is associ-
ated with inhibition of mPTP and early signs of apoptosis [4,5].
In addition to that, it has been already shown that mitochondria
from hepatoma cells exhibit alleviated mitochondrial cholesterol
content correlating with malignancy [29]. Altogether, the data
published so far and our own results indicate that pharmacological
modulation of mitochondrial cholesterol level seems to be of po-
tential clinical importance.
In conclusion, our data suggest that MbCD-induced disruption
of mitochondrial raft-like microdomains impairs the bioenergetics
of RLM stimulating changes in mitochondrial conﬁguration state,
and in the same time partially inhibits calcium chloride-induced
mitochondrial swelling.
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